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Introduction: 
Anaesthesia for neurosurgery has many challenges. The emphasis remains on the 
provision of good operative conditions, assessment and preservation of neurological 
function, and a rapid, high-quality recovery. Fluid management intraoperatively plays a 
major role in achieving these goals of neurosurgery. Candidates presenting for 
intracranial surgery may be at risk of hypovolaemia for different reasons, including 
insufficient fluid intake, physiological compensation for arterial hypertension, and 
osmotic diuretic therapy. Formula based fluid management is inappropriate in these 
situations and so therapy has to be individualised. Individualised ‘Goal-directed fluid 
therapy’ has been shown to improve outcome after surgery.  Various indices have been 
derived to calculate fluid responsiveness and volemic status. These include O2 
transport and hemodynamic variables such as mixed venous saturation, O2 delivery, 
stroke volume estimation, and pulmonary artery pressure which can be measured only 
with highly invasive monitoring. Dynamic indices such as pulse pressure variation, 
stroke volume variation and systolic pressure variation are considered reliable monitors 
for fluid responsiveness and are more practical. Among these, pulse pressure variation 
has been shown to have a high sensiivity and specificity. Our aim in this study was to 
see if fluid therapy guided by PPV variation is reliable in neurosurgical patients and to 
compare this with CVP guided therapy.  
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Aims and objectives: 
To study the use of PPV as index of fluid management in neurosurgery and compare this with 
CVP 
To assess the intraoperative hemodynamic stability using this therapy 
To study the adequacy of tissue perfusion at the end of surgery as measured by acid base and 
lactate levels and post operative fluid management. 
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Review of literature             
Fluid management in neurosurgery provides special challenges to the anaesthesia 
provider. The traditional approach to fluid management of patients with intracranial 
mass lesions or brain swelling often includes volume restriction to less than 1 litre/day. 
Though comfortable for the surgeon, the severe volume restriction leads to few major 
problems for the anesthesiologist e.g. hypovolaemia, electrolyte and acid base 
abnormalities and hypoxaemia. It has been  shown that complete water restriction in 
dogs for 72 hours results in an 8.0% loss of body weight but only 1% decrease in brain 
water content (1).The modern approaches to management require that patient have 
reasonable circulating volumes to tolerate the changes induced by  anaesthesia , 
surgery and other associated causes .(2) 
 
Special considerations in neurosurgery:  
The traditional approach for fluid management in patients with supratentorial masses 
and brain injury was to restrict fluids in an attempt to reduce brain volume and reduce 
cerebral edema. When used in conjunction with mechanical ventilation and osmotic 
dieresis it can produce a significant deficit in the functional circulating blood volume 
leading to hypotension, exaggerated circulatory responses to anaesthetic agents, 
hypoxemia and possible decrease in vertebral blood flow. Factors to be considered in 
fluid administration in neurosurgery are effects of fluids on intracranial volume, pressure 
and cerebral perfusion, the blood brain barrier and its role in fluid equilibrium, problems 
of hypo and hypervolemia in neurosurgery patients. (3) 
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 Preservation of CPP (cerebral perfusion pressure) 
Brain being encased within the skull increases in intracranial volume may produce 
deleterious increases in intracranial pressure. This can decrease cerebral perfusion 
resulting in ischemia and brain damage. Many mechanisms can increase the volume of 
the intracranial contents and ICP(intracranial pressure) 
Brain mass may increase from the growth of tumours 
Accumulation of blood either subdural, epidural or intracerebral  
Increase in the volume of Cerebrospinal fluid  
ICP can also increase secondary to vasodilation, which may be secondary to 
hypercapnea, hypoxemia, inhalation anaesthetics, intravenous anaesthetics like 
ketamine, direct acting vasodilators like nitroglycerine and nitroprusside or an initial 
effect of osmotic diuretics. Increase in central venous pressure by overhydration   can 
also increase brain vascular volume and intracranial hypertension. 
 
Preservation of CPP necessitates maintenance of normovolemia without adversely 
influencing intracranial pressure (ICP). Several physiologic principles underlie the 
relationship between fluid management, volume status and ICP. Cerebral blood volume 
(CBV) is a function of cerebral blood flow and cerebral venous volume, which in turn is a 
function of cerebral venous capacitance and cerebral venous pressure. Cerebral 
venous pressure is equal to central venous pressure in the supine position but is 
reduced as the head is elevated above the chest.  Even though it was assumed that 
hypervolemia would be associated with greater central venous pressure, and, as a 
consequence, greater cerebral venous pressure and greater intracranial volume, few 
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clinical data support that assumption. Although relative fluid restriction has been 
associated with worse outcome in head-injured patients,(4) more aggressive fluid 
therapy has been associated with greater severity of pulmonary infiltrates. Brain tissue 
volume is a function of the integrity of the blood-brain barrier (BBB). In non-brain 
tissues, and in brain tissue in which the BBB has been damaged, the distribution of fluid 
between plasma volume and extracellular volume (ECV) is determined by capillary 
membrane permeability, transcapillary hydrostatic pressure gradients and transcapillary 
colloid osmotic (oncotic) pressure gradients as defined by the formula  
Fluid movement = K(Pc+πi-Pi-πc) 
K – filtration coefficient 
Pc- hydrostatic pressure in the intravascular space 
Pi- hydrostatic pressure in the interstitial space 
Πc- colloid oncotic pressure in capillary 
Πi- colloid oncotic pressure in interstitium. 
 
In contrast to systemic capillary membranes, the cerebral capillary membranes that 
constitute the BBB are impermeable to most hydrophobic solutes, including sodium, but 
may become highly permeable if the BBB is disrupted. The terms hypotonic, isotonic 
and hypertonic refer to intravenous fluids in which the total osmolality is less than, 
roughly equal to, or greater than serum osmolality, with [Na+] in fluids relative to plasma 
[Na+] being the most important component of osmolality. Normal plasma osmolality 
averages 290mOsm/kg, of which 280mOsm/kg is attributable to sodium and its 
associated anions. The osmolalities of lactated Ringer’s solution and 0.9% NaCl are 
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270mOsm/kg and 308mOsm/kg, respectively. Each mOsm/kg difference across a 
water-permeable membrane generates an osmotic pressure of 19.3 mmHg. Because 
each sodium ion is accompanied by an anion, an acute increase or decrease of plasma 
sodium of 1.0mEq/L generates an acute increase or decrease in osmolality of 2.0 
mOsm/kg and an increase or decrease in osmotic pressure of 38.6 mmHg. Therefore, 
small acute differences in plasma sodium concentration ([Na+]) generate substantial 
osmotic pressure gradients across the intact BBB and may alter brain water to a 
clinically important extent.(5)  
In summary blood brain barrier creates a semipermeable barrier between blood 
and brain. Administration of large quantities of water or glucose solutions will lead to an 
increase in brain water and ICP. Administration of isoosmotic saline or albumin have 
little effect on brain water and ICP while hyperosmotic solutions which do not cross 
blood brain barrier will decrease brain water content. With disruption of blood brain 
barrier the permeability to sodium, albumin and mannitol is increased.(5) 
 
Hypertonic solutions:  
Osmotic reduction of brain water and ICP is routinely accomplished with mannitol 
but hypertonic saline solutions are preferred by some clinicians.(6) Hypertonic saline 
solutions and mannitol solutions of similar osmolality have similar effects on brain water 
and intracranial pressure. Infusion of hypertonic saline, unlike mannitol, increases 
intravascular volume.  While few complications relate specifically to osmotic therapy, 
acute severe hyperosmolality could theoretically precipitate BBB opening. Clinical use 
of hypertonic saline is associated, as is 0.9% saline, with hyperchloremic acidosis, 
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which usually requires no treatment, but must be differentiated from other causes of 
metabolic acidosis. (6) 
 
Guidelines for fluid management in craniotomy: 
As a general rule, isotonic crystalloid solutions should be used to replace preexisting 
deficits and blood loss. Transfusion may be indicated at a hemoglobin concentration 
([Hgb]) of 8 g/dL, with a higher threshold being appropriate if there is evidence of tissue 
hypoxia or ongoing uncontrolled haemorrhage. Fresh frozen plasma may be infused if 
there is persistent haemorrhage despite adequate surgical hemostasis. There are few 
clear indications for the administration of albumin or synthetic colloids; they do not 
prevent the formation of brain edema. Hetastarch, in sufficient quantities, may be 
associated with coagulopathy. To reduce brain volume and improve operating 
conditions, hypertonic mannitol is frequently given, with hypertonic saline representing 
an alternative. In 238 neurosurgical patients randomized to receive either 160 mL of 3% 
saline or 15mL of 20% mannitol to induce brain relaxation during neurosurgery, brain 
relaxation was superior in the group receiving 3% saline, although there were no 
differences in major outcomes.8 Solutions containing dextrose are best avoided unless 
there is a specific indication for use (e.g., hypoglycemia).(4) 
 
 
Restricted vs standard fluid management:   
 Optimal fluid management in high risk surgery  has been shown to decrease post 
operative morbidity and decrease duration of hospital stay.(3)(7)(8)(9) The amount of 
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fluid and the type of fluid to be used has been a matter of debate and no single index 
has been suggested to define optimal fluid management. Studies comparing high and 
low volume loading of patients have been done and the post operative parameters like 
post operative complications and duration of hospital stay have been studied.(10)(11). 
Brandstrup et al (12)studied restricted Vs standard fluid therapy in patients posted for 
colorectal surgery. In the randomised control trial they found less complications and 
reduced hospital stay in the patients who received restricted fluid therapy.(13) However 
MacKay et al (14) found conflicting results in a similar randomised control trial done in 
patients undergoing colorectal surgery. The aim of this study was to compare outcome 
following administration of restricted or standard postoperative intravenous fluids and 
sodium in patients undergoing elective colorectal surgery. Eighty patients were 
randomized to restricted fluids (less than 2 litres water and 77 mmol sodium for 24 h 
after surgery) or a standard postoperative fluid regimen (3 litres water and 154 mmol 
sodium per day for as long as necessary). The primary endpoint was hospital stay.   
The median total intravenous fluid intake in the restricted group was 4.50 (4.00-5.62) 
litres compared with 8.75 (8.00-9.80) litres in the standard group (P < 0.001). 
Intravenous sodium intake was also significantly less in the restricted group; P < 0.001). 
There was no difference in median time to first flatus or first bowel motion (P = 0.802) 
between the restricted and standard groups, or in median hospital stay (P = 0.902). 
They concluded that restriction of intravenous fluids during surgery did not reduce post 
operative stay in hospital.(14) However there are studies to the contrary too(15)(16) 
Various fluid indices have been used to direct fluid management .  Static measurements 
include estimates of preload of the patient like central venous pressure (CVP) , capillary 
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wedge pressure(PCWP) 
Central venous pressure:  
The measurement of central venous pressure (CVP) is very common in clinical practice. 
The CVP can be obtained with transducers and electronic monitors, witha simple water 
manometer, and even by simply measuring  jugular venous distension (JVD) on 
physical examination. The origins of CVP monitoring can be traced back to Hughes and 
Macgovern who described a complicated technique for right atrial monitoring to guide 
fluid replacement (17) 
Physiologic principles 
Two reasons for measuring the CVP are assessment of volume status and assessment 
of the preload of the heart, but a measurement of CVP alone cannot achieve these 
objectives. This is because CVP and cardiac output are determined by the interaction of 
two function curves: the cardiac function curve and the return curves.(18). A value of 
CVP cannot be interpreted without some idea of cardiac output at the time of the 
measurement. This does not have to be an actual measurement of cardiac output and 
could include a clinical assessment of the patient’s perfusion status (19) 
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 The second physiological principle in CVP measurement is the concept of physiologic 
limits. The cardiac function curve has a steep ascending portion and then reaches a 
plateau (20) The plateau occurs because there is a limit to diastolic filling of the heart, 
which generally occurs first in the right ventricle. Under normal conditions, this limitation 
is due to constraint by the pericardium, but even in the absence of a pericardium, the 
cardiac cytoskeleton limits cardiac filling implying that the heart cannot be easily 
overfilled and there is no downward slope to the Starling curve. Limitation of filling in the 
right side of the heart also limits ejection from the right side of the heart, which thereby 
protects the left side of the heart and the lungs. Patients on the flat part of the curve will 
not have an increase in cardiac output with fluid boluses.(21) 
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Principles of measurement:  
Two concepts are especially important: the concept that pressures are relative to an 
arbitrary reference point and the concept of transmural pressure. When a fluid filled 
catheter is used to measure central venous pressure it has to be referenced to an 
arbitrary point, the commonly accepted point of reference for hemodynamic 
measurements is the midpoint of the right atrium, where the heart interacts with the 
returning blood. This point in the supine position is referenced to the fifth intercostal 
space on a line from the midaxilla . The midaxilla measurement gives a CVP value that 
is approximately 3 mm Hg higher than measurements based on the sternal angle  
Electronic measurement of central venous pressure 
The CVP has three prominent positive waves: the ‘a,’ ‘c,’ and ‘v’ waves and two 
prominent negative waves, the ‘x’ and ‘y’ descents. The ‘a’ wave is due to atrial 
contraction, the ‘c’ wave is due to the backward buckling of the tricuspid valve at the 
onset of systole, and the ‘v’ wave is due to atrial filling during diastole. The ‘x’ descent is 
due to the fall in atrial pressure during relaxation of the atrial contraction. The ‘y’ 
descent is due to the sudden decrease in atrial pressure at the onset of diastole when 
the atrioventricular valve opens and allows the atrium to empty into the ventricle. The ‘y’ 
descent is affected by the relative filling of the atria and ventricles at the start of diastole, 
the compliance of the chambers, and the pressure outside the heart (22). This last 
factor can be useful for marking inspiration on the hemodynamic recording in patients 
with spontaneous breaths, for the ‘y’ descent increases during inspiration.  Since the 
most common reason for assessing CVP is likely the assessment of cardiac preload the 
best place for the measurement is the ‘z’ point, which is at the leading edge of the ‘c’ 
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wave, which gives the final pressure in the atrium and thus the ventricle just before 
ventricular contraction 
 
 
 
 Fluid responsiveness  
It is important to be able to recognize the plateau of the cardiac functions curve because 
it indicates the limits of volume responsiveness of the heart. The value at which this 
plateau occurs is highly variable among individuals. Patients can be volume limited at 
CVP values as low as 2 mm Hg , whereas others may respond at CVP values greater 
than 18 mm Hg. Magder et al found 40% of patients, with a CVP below 6 mm Hg did not 
respond to fluids . Most patients will be volume limited by a CVP of 10 to 12 mm Hg, 
and this range of CVP can be considered high. When giving volume challenges to 
patients with CVP values above this range, one should have some reason to expect that 
transmural right atrial pressure is less than is evident from the CVP relative to 
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atmosphere. Possibilities include patients with high positive end-expiratory pressure, 
thickened right ventricular walls, high abdominal pressure, and cardiac compression by 
the lungs or mediastinum. When possible, however, it is best not to use a single value 
of CVP to predict volume responsiveness, and some kind of dynamic test should be 
used. It also must be emphasized that just because a patient is fluid responsive does 
not mean that the patient needs fluid. Normal persons will usually have an increase in 
cardiac output in response to a fluid bolus. 
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Fluid challenge:  
The gold standard for testing volume responsiveness is to give a fluid challenge fluid 
bolus is infuse rapidly to increase the CVP by 2 mm Hg and then determine whether 
there is an increase in cardiac output. (23) .The number of 2mm Hg is picked because a 
change of this magnitude can be identified with confidence on most monitors and 
recording devices. The change in cardiac output should be in the range of 300 ml/min.  
To minimize the amount of fluid needed, the fluid must be given quickly. If the fluid is 
given rapidly and the change in CVP is monitored continuously, the type of fluid does 
not matter.(19) The faster the fluid is given, the less is needed. When a measure of 
cardiac output is not available, other surrogate markers can be used. A change in 
arterial pressure does not correlate well with changes in cardiac output.(22) 
 
‘y’ descent 
Another indicator that there will not be an increase in cardiac output with a volume 
infusion is the magnitude of the ‘y’ descent. The presence of a large y descent indicates 
restriction of right ventricular filling (22) . This can be due to intrinsic stiffness of the 
ventricular wall or occur in a ventricle that is excessively volume-loaded. In either case, 
further volume loading is unlikely to change cardiac output. Madger et al found that 
when the y descent is >4mmHg the patient is unlikely to have a rise in cardiac output in 
response to a volume challenge .(24) 
The magnitude of the Y descent is affected by the volume status, the magnitude and 
direction of the changes in pleural pressure, and the compliance of the pericardial 
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compartment. A large Y descent indicates a restrictive cardiac state, but a small Y 
descent does not rule out a restrictive condition because of the many interacting 
variables. 
.  
Respiratory variation of CVP 
The respiratory pattern in CVP can be used to predict fluid responsiveness (23) 
Patients who have no inspiratory fall in CVP are on the flat part of their cardiac function 
curve and will not respond to fluids whereas patients who have an inspiratory fall in CVP 
are on the ascending part of the cardiac function curve and may or may not respond to 
fluids. Clinically useful information can also be obtained from the magnitude of the 
respiratory swings in CVP. In spontaneously breathing individuals a large fall inspiratory 
fall in CVP indicates that there was a large fall in pleural pressure.(23) 
 
Placement of central venous catheter 
CVP measurement requires placement of a central venous line. The following 
considerations need to be given in the placement of a line: Reliability of correct 
placement, prediction of the correct value, feasibility of line placement. Various methods 
and landmarks have been studied for measuring CVP.  
Common sites for central line placement include internal jugular vein or subclavian vein 
on either side and femoral vein. Peripherally inserted central lines (PICC) can be 
inserted in the antecubital fossa through the median basilic or cephalic vein and are 
inserted till the catheter tip resides in a central vein. Comparison of CVP measurements 
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have been done from catheters placed in various positions and the accuracy 
determined.  
 
Measurement of CVP: 
CVP measurement can vary when measured by central line and PICC line .It was 
postulated that because of their longer length and narrower lumen, PICCs have a higher 
inherent resistance that makes them an inappropriate vehicle to measure central 
venous pressure without methodological modification. 
Black et al studied the CVP measurement from central line and PICC line. They used a 
continuous infusion device to overcome the PICC’s inherent resistance.  A pressure 
difference of 3-4 mmHg was expected based on in vitro studies. However their study 
showed that the difference in measurement was only 1 mmHg.(25) PICC line can act as 
an additional tool for assessing patients’ intravascular volume status, with a reported 
decrease in cost and risks (26)(27).  Although PICCs are associated with decreased 
infection rates and a decreased incidence of pneumothorax,, PICCs may be associated 
with an increase in catheter malposition, inadvertent removal, and severed or leaking 
catheters, when compared with CICCs (27)(28). 
Methods of central venous cathether placement:  
Placement of a central line can be done using various methods. Anatomical landmarks 
can be used to decide site of puncture. Alternatively when the resources are available 
placement can be ultrasound guided and electrocardiogram guided. Studies have been 
done to compare efficacy of placement and the depth of placement.  
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The standard technique for placement of central venous catheters is by use of 
anatomical landmarks, which may not correlate with vessel location (29). The use of 
Doppler ultrasound to assist with catheter placement was first reported in 1984 (9). 
Ultrasonography for vessel location with subsequent catheter placement by landmark 
technique was later shown to have no effect on the complication or success rate of 
subclavian catheterization(16 ) (30) .Randolph et al (31) did a meta analysis of 
placement of central lines by various methods.  
The outcomes assessed were the rapidity of placement, the number of attempts before 
successful placement, the success of placement, the rate of complications, and the rate 
of success after failure by the landmark method. From a pool of 208 randomized, 
controlled trials of venous and arterial catheters management, 12 randomized, 
controlled trials of ultrasound guidance or Doppler ultrasound guidance for placement of 
central venous or pulmonary artery occlusion pressure catheters in adult patients were 
identified. They found that compared with the landmark technique for placement of 
internal jugular and subclavian central venous catheters, ultrasound guidance 
significantly increases the probability of successful catheter placement, significantly 
reduces the number of complications encountered during catheter placement, and 
significantly decreases the need for multiple catheter placement attempts. However, the 
time it takes to successfully place a catheter may not be reduced using ultrasound 
guidance. 
Unavailability of ultrasound device and lack of expertise limit the use of ultrasound.  
However other methods can be used for placement as well.ECG controlled placement 
of central line was introduced in 1949.  
23 
 
Gebhard et al (21) conducted a trial to estimate accuracy of line placement by this 
method . Guidewire-ECG control resulted in more correctly positioned CVCs (96% vs 
76%, P < 0.001) without increasing placement time. Significantly more CVCs were 
placed in the middle of the superior vena cava in group ECG (P _ 0.001), although 
placement into the right atrium or right ventricle and into other vessels occurred 
significantly more often in group NO-ECG (P _ 0.001) 
They concluded that when available ECG should be used to position to avoid 
complications associated with line placement and to avoid costs of repositioning of 
central line.(32)  
ECG guided placement of central line:  
Cotrell described optimal positioning of central line for air aspiration (33)For introduction 
of catheter  venipuncture is made by the modified Seldinger technique. The catheter is 
advanced alteast 20 cm via the arm or 15 cm via the neck. Specially adapted conducted 
connector for ECG attachment is placed on the guidewire . The monitor ECG is set for 
lead II and the right arm lead is connected to the connector. The ECG trace is observed 
on the monitor and the tip is manipulated until it lies in the right ventricle .The catheter is 
then withdrawn into the mid- right atrium to detect a biphasic P wave. The catheter is 
then withdrawn until the P wave is approximately the height of the QRS complex. It is 
then withdrawn some more till the P wave is smaller than the QRS complex and fixed at 
this point (34)(35) 
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The use of ECG for central line placement has been supported by many studies. The 
use of this method has been proven to predictably improve aspiration of air from right 
atrium   and decrease need for chest x ray for line placement.(36) (37) 
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As shown in figure catheter is withdrawn till p wave is biphasic and as tall as the QRS 
complex . 
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The catheter is further withdrawn till the height of the p wave is smaller than QRS and 
anchored at this point  
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Central venous pressure has been used to predict fluid responsiveness. However Marik 
et al (27) have done a systematic review to study the relationship  between CVP and 
blood volume,  the ability of CVP to predict fluid responsiveness, and the ability of the 
change in CVP to predict fluid responsiveness. Of the 24 studies included in this 
analysis, 5 studies compared CVP with the measured circulating blood volume while 19 
studies determined the relationship between CVP and change in cardiac performance 
following a fluid challenge (generally defined as a _ 10 to 15% increase in stroke index/ 
cardiac index). In all, 830 patients across a spectrum of medical and surgical disciplines 
were studied. 
 
The results of this systematic review are clear: (1) there is no association 
between CVP and circulating blood volume, and (2) CVP does not predict fluid 
responsiveness across a wide spectrum of clinical conditions.  The likelihood that CVP 
can accurately predict fluid responsiveness is only 56% The results from this study 
therefore confirm that neither a high CVP, a normal CVP, a low CVP, nor the response 
of the CVP to fluid loading should be used in the fluid management strategy of any 
patient. None of the studies included in the analysis took the positive end-expiratory 
pressure levels or changes in intrathoracic pressure into account when measuring CVP. 
This is important because right ventricular filling is dependent on the transmural right 
atrial pressure gradient rather than the CVP alone. The practice parameters for 
hemodynamic support of sepsis in adult patients concludes that “fluid infusion should be 
titrated to a filling pressure” and that “pulmonary edema may occur as a complication of 
fluid resuscitation and necessitates monitoring of arterial oxygenation. This is clinically 
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important because a positive fluid balance in both ICU patients and those undergoing 
surgery has been associated with increased complications and a higher mortality. It is 
however equally likely that resuscitation guided by CVP will result in inadequate volume 
replacement. Furthermore, the use of diuretics based on CVP may result in 
intravascular volume depletion leading to poor organ perfusion and ultimately renal 
failure and multi organ failure because a “high” CVP does not necessarily reflect volume 
overload.(38) 
 
The only reason to give a patient a fluid challenge is to increase the stroke volume. This 
assumes that the patient is on the ascending portion of the Frank-Starling curve and 
has “recruitable” cardiac output. Once the left ventricle is functioning near the “flat” part 
of the Frank-Starling curve, fluid loading has little effect on cardiac output and only 
serves to increase tissue edema and to promote tissue dysoxia. It is therefore crucial 
during the resuscitation phase of all critically ill patients to determine whether the patient 
is fluid responsive or not; this determines the optimal strategy of increasing cardiac 
output and oxygen delivery. Marik et al suggest clearly that CVP should not be used for 
this purpose . 
In 1971, Forrester and colleagues,  the pioneers of hemodynamic monitoring, 
concluded that “CVP monitoring in acute myocardial infarction is at best of limited value 
and at worst seriously misleading.” (39)In 1977, Dr. Burch, a well respected cardiologist, 
noted that “to accept non critically the level of central venous pressure as a quantitative 
index of blood volume can only lead to physiologic and/or  therapeutic errors.”(40) The 
observations of Forrester et al, Baek and colleagues (41) , and Burch have now been 
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confirmed by 23 more recent studies. Magder reported that the respiratory variation in 
CVP in spontaneously breathing patients was predictive of fluid responsiveness. 
Additional studies are required to support using the respiratory variation in CVP to guide 
fluid management. 
Hence it can be stated that CVP is a measure of right atrial pressure alone; and not a 
measure of blood volume or ventricular preload. However, measurement of the CVP 
may be useful in select circumstances, such as in patients who have undergone heart 
transplant, or in those who have suffered a right ventricular infarction or acute 
pulmonary embolism. In these cases, CVP may be used as a marker of right ventricular 
function rather than an indicator of volume status. This forms the basis to hemodynamic 
monitoring. (40) 
 
Hemodynamic monitoring:  
Measurements of indices like CVP and PAOP are not fully reliable with wide variations 
in intrathoracic pressures .They act as a poor estimate of preload as preload depends 
on ventricular volumes. To overcome the limitations of these static indices dynamic 
indices have been devised and used. These indices are based on the response of the 
circulatory system to a controlled preload variation by specific maneuvers redistributing 
blood volume (eg:mechanical ventilation, leg raising).(42) 
Classification of dynamic indices: 
Dynamic indices can be classified according the methodology used to predict preload 
variation. First group of indices are those which depend on cyclic variations of stroke 
volume or stroke volume related hemodynamic parameters like pulse pressure or aortic 
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blood flow determined by mechanical ventilation induced variations in intrathoracic 
pressure. Second group of indices are those based on cyclic variation of non stroke 
volume related hemodynamic parameters like vena cava diameter determined by 
mechanical ventilation. Third group are  based on preload redistribution manoeuvres 
like passive  leg raising.  
Group A indices are the following:  
Delta down: difference between apnoeic and tele expiratory systolic arterial 
pressure.(minimal value during mechanically ventilated cycle) 
Delta Up: difference between tele inspiratory and apnoeic systolic arterial 
pressure (maximal value during mechanically ventilated cycle) 
Systolic pressure variation: systolic arterial pressure variation during 
mechanically ventilatory cycle delta up+ delta down 
Pulse pressure variation:  arterial pulse pressure variation during mechanically 
ventilatory cycle. 
Stroke volume variation: stroke volume variation during mechanically 
ventilatory cycle. 
Peak aortic flow velocity variation: peak aortic blood flow velocity variation 
during mechanical ventilation. 
Group B indices:  
Left ventricle pre ejection period variation(delta PEP) 
Ventilation induced variation of left ventricle pre ejection period or isovolumetric 
contraction time 
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Plethysmography delta PEP: calculated from plethysmography from R wave to 
the foot of plethysmographic wave. 
Superior vena cava collapsibility index: ventilation induced variation of 
superior vena cava diameter. 
Inferior vena cava distensibility index: ventilation induced variation in inferior 
vena cava diameter. 
Group C indices:  
Inspiratory right atrial pressure index:  
Spontaneous inspiration induced right atrial pressure variation 
Aortic blood flow variation due to passive leg raising:  
Difference between aortic blood flow during passive leg  raising and baseline 
aortic blood flow. 
Respiratory systolic variation test:  
Lungs are inflated with increasing airway pressures. systolic arterial pressure is 
measured after every inflation, so inflation induced variation in pressure can be 
calculated. 
 
Physiological principles:  
Effect of mechanical ventilation on right and left ventricular stroke volume 
During mechanical ventilation the right ventricular stroke volume decreases and 
the left ventricular stroke volume increases with the opposite phenomenon happening 
during expiration. These physiological decreases are seen normally in patients but are 
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much wider when there is hypovolemia as their amplitude is predictive of fluid 
responsiveness. 
Respiratory changes in right atrial pressure in spontaneously breathing patients 
In patients with significant spontaneous breathing activity, the respiratory 
changes in right atrial pressure have been proposed to differentiate patients whose 
hearts are functioning on the flat part of the cardiac function curve from those who still 
have volume reserves and are on the ascending part of the curve. Unfortunately, many 
patients  not have adequate inspiratory effort, and therefore do not have sufficient fall in 
pleural pressure to use this test to predict fluid responsiveness. 
 
Respiratory changes in LV stroke volume in mechanically ventilated patients 
In mechanically ventilated patients, the magnitude of the respiratory changes in 
LV stroke volume can be used to assess fluid responsiveness. Intermittent positive-
pressure ventilation induces cyclic changes in the loading conditions of right and left 
ventricles. Mechanical insufflations decreases preload and increases afterload of the 
right ventricle . The inspiratory impairment in venous return is assumed to be the main 
mechanism of the inspiratory reduction in RV ejection (43). The inspiratory reduction in 
RV ejection leads to a decrease in LV filling after a phase lag of two to three heart beats 
because of the long blood pulmonary transit time . Thus, the LV preload reduction may 
induce a decrease in LV stroke volume, which is at its minimum during the expiratory 
period. 
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 Respiratory changes in systolic pressure 
 
 
  In 1983, Coyle et al proposed that the respiratory changes in systolic pressure 
could be analyzed by calculating the difference between the maximal and the minimal 
value of systolic pressure over a single respiratory cycle .This difference was called 
‘systolic pressure variation’ (SPV) and was divided into two components (delta up and 
delta down). These two components are calculated using a reference systolic pressure, 
which is the systolic pressure measured during an end-expiratory pause. Delta up is the 
difference between the maximal value of systolic pressure over a single respiratory 
cycle and the reference systolic pressure. It reflects the inspiratory increase in systolic 
pressure.Delta down is the difference between the reference systolic pressure and the 
minimal value of systolic pressure over a single respiratory cycle. It reflects the 
expiratory decrease in LV preload and stroke volume related to the inspiratory decrease 
in RV stroke volume. 
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Respiratory changes in pulse pressure 
The pulse pressure (defined as the difference between the systolic and the 
diastolic pressure) is directly proportional to LV stroke volume and inversely related to 
arterial compliance .  The pulse pressure is not directly influenced by the cyclic changes 
in pleural pressure, because the increase in pleural pressure induced by mechanical 
insufflation affect both diastolic and systolic pressures. In this regard, the respiratory 
changes in LV stroke volume have been shown to be reflected by changes in peripheral 
pulse pressure during the respiratory cycle [23]. Therefore, 
it was recently proposed that fluid responsiveness may be assessed by calculating the 
respiratory changes in pulse pressure (DPP) as follows: 
(PPmax – PPmin) 
DPP (%) = 100 × (PPmax + PPmin)/2 
where PPmax and PPmin are the maximal and minimal values of pulse pressure over a 
single respiratory cycle. 
DPP accurately predicted the haemodynamic effects of volume expansion; a threshold 
value of 13% allowed discrimination between responder (defined as patients who 
experienced an increase in cardiac index ³15% in response to volume expansion) and 
non responder patients with a sensitivity and a specificity of 94 and 96%, respectively. 
Delta PP was a more reliable indicator of fluid responsiveness than the respiratory 
changes in systolic pressure(23) .The decrease in DPP induced by volume expansion 
was correlated with the increase in cardiac index, such that changes in DPP could be 
used to assess the haemodynamic effects of volume expansion. 
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Various studies have been done using these dynamic indices as markers of volume in 
patients.  
Until now, delta PP has had to be calculated offline (from a computer recording 
or a paper printing of the arterial pressure curve), or to be derived from specific cardiac 
output monitors, limiting the widespread use of this parameter. Recently, a method has 
been developed for the automatic calculation and real-time monitoring of deltaPP using 
standard bedside monitors. Auler et al (44) studied this method to predict if delta PP is 
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a   reliable predictor of fluid responsiveness.They conducted a prospective clinical study 
in 59 mechanically ventilated patients in the postoperative period of cardiac surgery. 
Patients studied were considered at low risk for complications related to fluid 
administration (pulmonary artery occlusion pressure < 20 mm Hg, left ventricular 
ejection fraction > or = 40%). All patients were instrumented with an arterial line and a 
pulmonary artery catheter. Cardiac filling pressures and cardiac output were measured 
before and after intravascular fluid administration (20 mL/kg of lactated Ringer's solution 
over 20 min), whereas deltaPP was automatically calculated and continuously 
monitored. 
Results of the study were as follows:  
Fluid administration increased cardiac output by at least 15% in 39 patients (66% = 
responders). Before fluid administration, responders and nonresponders were 
comparable with regard to right atrial and pulmonary artery occlusion pressures. In 
contrast, deltaPP was significantly greater in responders than in nonresponders (17% 
+/- 3% vs 9% +/- 2%, P < 0.001). The deltaPP cut-off value of 12% allowed identification 
of responders with a sensitivity of 97% and a specificity of 95%. 
They concluded that automatic real-time monitoring of deltaPP is possible using a 
standard bedside monitor and was found to be a reliable method to predict fluid 
responsiveness after cardiac surgery. (44) 
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As shown in the figure the PPV is displayed as a number calculated from the arterial 
pressure curve . 
Bias et al (45)studied the abilities of pulse pressure variations and stroke volume 
variations to predict fluid responsiveness in prone position during scoliosis surgery . The 
aim of the study was to evaluate the ability of PPV and SVV to predict fluid 
responsiveness in mechanically ventilated patients in the prone position (PP) during 
scoliosis surgery.Thirty subjects were studied after the induction of anaesthesia in the 
supine position [before and after volume expansion (VE) with 500 ml of hetastarch 6%] 
and in PP (immediately after PP and before and after VE). PPV, SVV, cardiac output 
(CO), and static compliance of the respiratory system were recorded at each interval. 
Subjects were defined as responders (Rs) to VE if CO increased _15%.Results: Three 
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subjects were excluded. In the supine position, 16 subjects were Rs. PPV and16 
subjects were Rs. PPV and SVV before VE were correlated with VE-induced changes in 
CO . Fluid responsiveness was predicted in PP by PPV .15%  and by SVV .14% (45) 
Kramer et al (46) studied   PPV in post coronary artery bypass grafting and the ability 
to predict fluid responsiveness.The study was done to determine whether the degree of 
pulse pressure variation (PPV) and systolic pressure variation (SPV) predict an increase 
in cardiac output (CO) in response to volume challenge in postoperative patients who 
have undergone coronary artery bypass grafting (CABG), and to determine whether 
PPV is superior to SPV in this setting. It was a prospective clinical study conducted in 
the cardiovascular ICU of a university hospital. Twenty-one patients were studied 
immedVZDiately after arrival in the ICU following CABG .Intervention done was to 
administer a fluid bolus to all patients.   
Hemodynamic measurements, including central venous pressure (CVP), pulmonary 
artery occlusion pressure (PAOP), CO (thermodilution), percentage of SPV (%SPV), 
and percentage of PPV (%PPV), were performed shortly after patient arrival in the ICU. 
Patients were given a rapid 500-mL fluid challenge, after which hemodynamic 
measurements were repeated. Patients whose CO increased by ≥ 12% were 
considered to be fluid responders. The ability of different parameters to distinguish 
between responders and nonresponders was compared.  
Results: In response to the volume challenge, 6 patients were responders and 15 were 
nonresponders. Baseline CVP and PAOP were no different between these two groups. 
In contrast, the %SPV and the %PPV were significantly higher in responders than in 
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nonresponders. Receiver operating characteristic curve analysis suggested that the 
%PPV was the best predictor of fluid responsiveness. The ideal %PPV threshold for 
distinguishing responders from nonresponders was found to be 11. A PPV value of  
>11% predicted an increase in CO with 100% sensitivity and 93% specificity. They 
concluded that PPV and SPV can be used to predict whether or not volume expansion 
will increase CO in postoperative CABG patients. PPV was superior to SPV at 
predicting fluid responsiveness. Both of these measures were far superior to CVP and 
PAOP (21)  
Similar results were found by Hofer et al who found that  in  contrast to standard 
preload indexes, SVV and PPV, comparably, showed a good performance in predicting 
fluid responsiveness in patients before off-pump coronary artery bypass grafting(46) 
De Backer et al (47) studied the influence of tidal volume on PPV and its ability to 
predict fluid responsiveness. Fluid challenge with either 1,000 ml crystalloids or 500 ml 
colloids.  Complete hemodynamic measurements including DeltaPP were obtained 
before and after fluid challenge. Tidal volume was lower than 7 ml/kg in 26 patients, 
between 7-8 ml/kg in 9 patients, and greater than 8 ml/kg in 27 patients. ROC curve 
analysis was used to evaluate the predictive value of DeltaPP at different tidal volume. 
Despite similar response to fluid challenge in low (<8 ml/kg) and high tidal volume 
groups, the percent of correct classification of a 12% DeltaPP was 51% in the low tidal 
volume group and 88% in the high tidal volume group. CONCLUSIONS: DeltaPP is a 
reliable predictor of fluid responsiveness in mechanically ventilated patients only when 
tidal volume is at least 8 ml/kg.(47) (48) 
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Benes et al(49) studied the use of stroke volume variation in patients coming for high 
risk major abdominal surgery  
The aim of the study was to evaluate the influence of SVV guided fluid optimization on 
organ functions and postoperative morbidity in high risk patients undergoing major 
abdominal surgery. Fluid optimization guided by SVV during major abdominal surgery is 
associated with better intraoperative hemodynamic stability  
hypotensive episodes were less p=0.0001, decrease in serum lactate p=0.025  at the 
end of surgery and lower incidence of postoperative organ complication p= .0066(49) 
 Lopes et al(50) studied Goal-directed fluid management based on pulse pressure 
variation monitoring during high-risk surgery in a prospective, randomized, single-centre 
study. The primary endpoint was the length of postoperative stay in hospital. Delta PP 
was monitored during the surgery and minimized to less than 10% by volume loading. 
They found that the study group received more fluids, had less complications in the post 
operative period p<0.05 and had shorter post operative stay in hospital p<0.05(51) 
Mayer et al(52) studied goal-directed intraoperative therapy based on autocalibrated 
arterial pressure waveform analysis in patients coming for abdominal surgery.  
The aim of this study was to perform intraoperative goal-directed therapy with a 
minimally invasive, easy to use device (FloTrac/Vigileo), and to evaluate possible 
improvements in patient outcome determined by the duration of hospital stay and the 
incidence of complications compared to a standard management protocol. In this 
randomized, controlled trial 60 high-risk patients scheduled for major abdominal surgery 
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were included. Patients were allocated into either an enhanced hemodynamic 
monitoring group using a cardiac index based intraoperative optimization protocol 
(FloTrac/Vigileo device, GDT-group, n = 30) or a standard management group (Control-
group, n = 30), based on standard monitoring data. In high-risk patients undergoing 
major abdominal surgery, implementation of an intraoperative goal-directed 
hemodynamic optimization protocol using the FloTrac/Vigileo device was associated 
with a reduced length of hospital sta.(P=0.0006), and a lower incidence of complications 
compared to a standard management protocol(P = 0.001).(53) 
Deflandre et al (53)compared delta down with delta pulse pressure as indicator of 
volemia in intracranial surgery.  
Delta pulse pressure (DPP) and delta down (DD) are indicators of volaemia. The 
threshold value of DPP for discriminating between responders and non-responders to 
fluid loading (FL) is 13%. This study aimed at comparing DD with DPP during 
intracranial surgery. 
 Twenty-six adult patients undergoing scheduled intracranial surgery under general 
anaesthesia were enrolled. DD and DPP were simultaneously measured every 10 min. 
A DPP.13% on two consecutive occasions prompted a 250 ml FL. Pairs of data were 
analysed using regression analysis, receiver operating characteristics (ROC) curve, and 
prediction probability (Pk). significant correlation ws found between  DD and DPP 
(R²0.5431, P,0.001). ROC curve analysis revealed an excellent accuracy of DD in 
predicting a DPP value higher or lower than 13% (area under the curve: 0.967, SE: 
0.013). The DD threshold associated with the best sensitivity (0.90) and specificity 
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(0.99) was 5 mm Hg. The Pk of DD to predict a DPP value higher or lower than 13% 
was 0.97 (SE: 0.01).They concluded that DD is as efficient as DPP to assess 
hypovolaemia and predict responsiveness to FL in patients undergoing intracranial 
surgery. A 5 mm Hg DD value can be considered as a valuable threshold for initiating 
FL. These results support its use during intracranial surgery 
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MATERIALS AND METHODS  
Type of study: A  randomised controlled trial. 
Inclusion criteria:  
Patients planned for craniotomy between the ages of 18- 80 years. 
Surgeries lasting more than two hours duration. 
Patients planned for craniotomy for tumour excision 
Surgery in Supine and lateral position  
 
 
Exclusion criteria:  
 
Patients with arrhythmia 
Patients with chronic obstructive lung diseases and those with poor chest compliance. 
Patients with  raised intra abdominal pressures. 
Patients who are not mechanically ventilated. 
Patients on drugs producing lactic acidosis including metformin.  
Patients in sepsis 
Patient with baseline lactate more than 4 
Patients undergoing surgery in prone and sitting position 
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Method of randomization 
Block randomization 
Method of allocation concealment: 
Sequentially numbered, sealed, opaque envelopes 
 
Methodology:  
Clearance was obtained from the institutional review boards and the ethics committee to 
perform the study in its present format. Once the randomization was done the patient 
was met by the investigator and informed consent obtained. The patient was fasted 
minimum of six hours for solids and two hours for liquids. Anxiolytic premedication was  
avoided in patients with  raised intracranial pressure.  
Intravenous infusion was started using a wide bore cannula in a peripheral vein and 
direct arterial pressure monitoring established under local anaesthesia. A baseline 
arterial blood gas was taken with patient breathing room air. Other monitoring included 
pulse oximetry, capnography  and electrocardiography. Anaesthesia was induced with 
thiopentone 5mg/kg, Fentanyl 2mcg/kg, and maintained on isoflurane end tidal 
concentration at 0.9% (MAC 0.8). in air and oxygen. Muscle relaxation was achieved 
using vecuronium 0.15mg/kg for endotracheal intubation and maintained with an 
infusion titrated to 2 twitches on neuromuscular monitoring. Patients were mechanically 
ventilated with a minimum of 8ml/kg of tidal volume and appropriate respiratory rate to 
achieve an ETCO2 between 30 and 35 mmHg.   
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Post induction, the right internal jugular vein was cannulated using a single lumen 
catheter (Arrow) in all patients guided by ECG. The catheter was advanced till a 
biphasic p wave was observed on the ECG and gradually withdrawn till peaked p waves 
were observed and the catheter was anchored at this depth. Baseline PPV was 
measured, once mechanical ventilation was ascertained and the tidal volume set at  
8ml/Kg,  in all patients. Simultaneously a baseline CVP was also measured. Based  on 
the randomisation,  CVP or PPV monitoring was used intra operatively to guide fluid 
management and the other monitor was discontinued till the end of surgery.  
 In the CVP group fluids were given to maintain the baseline value and all blood loss 
was promptly replaced. In the PPV group fluids were given to maintain the PPV less 
than 13%  and fluid boluses were given when more than this number. Normal saline and 
ringer lactate was used alternatingly. If the estimation of blood loss exceeded 500ml , 
colloid or blood was infused depending on the patient’s Hemoglobin with an aim to keep 
the Hemoglobin around 9 gm/dl. Forced air warming was used to maintain temperature 
which was measured with a probe in the nasopharynx.  If hypotension persisted despite  
normal CVP or PPV, this was treated with a vasopressor viz.  phenylephrine or 
ephedrine.  A second reading of PPV and CVP were taken before discontinuing 
mechanical ventilation (Final PPV or CVP)   
The total estimated blood loss was noted down at the end of surgery. Reversal of 
neuromuscular blockade was done with neostigmine and glycopyrolate. Patients were 
extubated when fully awake. Arterial blood gas was repeated when patients were  
maintaining saturation off oxygen and the vital signs were noted. Post operatively 
patients were shifted to the intensive care unit. The post operative follow up of the 
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patient was done after the first 24 hours. Fluid requirement and blood pressure 
fluctuations in the post operative period were recorded from the records of the patient. 
Statistical analysis: 
All baseline variables were summarized using descriptive statistical methods (Mean, 
Standard deviation, Frequencies and Percentages).  The outcome variables were 
compared between the two groups using Independent two-sample t-test, if they are 
normally distributed. For variables which are not normally distributed, Mann-whitney U 
test was used to compare the medians between the groups. Paired t-test was used for 
within group comparisons. All statistical analyses was done using SPSS 11.0. 
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Results: 
Total number of patients enrolled were 60. 3 patients were excluded as they 
required post operative ventilation. In the final analysis there were 29 patients in the 
CVP group and 28 in the PPV group 
Table 1 shows the patient characteristics, the two groups were similar with 
regard to age sex and ASA grading 
 Table 1:Demography   
                                                          CVP group                         PPV group 
                                                         Mean (SD)                        Mean(SD) 
Height 158.76(6.4) 156.93(5.9) 
Weight 57.55(9.7) 58.85(10.8) 
Age 43.44(10.26) 39.96(13.98) 
BMI 22.78(2.98) 23.83(3.75) 
Sex(M:F) 12:17 11:17 
ASA grade 1:2 21:8 21:7 
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The distribution of the various medications the patients were on is shown in table 2 
 
 Table 2:Medications: 
 
                                     CVP group                              PPV group 
 
 
 
 
 
 
 
 
Medications Number  % Number % P  
nil  1 3.45 0 0.00  
Antiepileptics 23 79.31 26 92.86 2.1
Steroids 22 75.86 24 85.71 0.8
OHA s 3 10.34 3 10.71 5.8
Insulin 0 0.00 1 3.57 
Antihypertensive 7 24.14 2 7.14 
lipid lowering drug 1 3.45 0 0.00 
aspirin  0 0.00 1 3.57 
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Distribution of comorbid illness in both groups were as described in table 3 
Table 3: Distribution of comorbid illness in both groups 
                                          
 
 
 
The groups were comparable with regards to the baseline investigations. Mean size of 
tumour was similar in both groups. The baseline pH, baseline lactate were also not 
different significantly.  
 
 
 
 
 
 
 
Comorbidity CVP group            PPV group 
Nil 20 22 
DM 2 4 
HT 8 3 
CAD 1 0 
Thyroid  1 1 
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Table 3: Baseline characteristics 
                                               CVP group                                               PPV group 
 
 
PCV 37.53  (4.89) 37.49 ( 4.75) 
S.Creatinine 0.878   (.158) 0.89  (0.15) 
Size of tumour 5.07 ( 1.4) 5.00 ( 1.79) 
Systolic pressure 
mmHg 
122.38  (26.81) 129.0     (25.94) 
Diastolic Pressure 
mmHg 
73.06  (10.25) 73.28  (11.3) 
Heart Rate /min 83.89  (14.27) 83.93  (13.8) 
pH 7.45  (0 .05) 7.44  (0.03) 
HCO3 25.63( 2.30) 24.16  (2.67) 
Lactate 1.95  (0.67) 2.40  (1.65) 
Na 134.76 ( 3.0) 135.43( 2.7) 
K 3.81( 1.1) 3.78(0 .33) 
Ca 1.09( .07) 1.11(0 .044) 
Cl 107.9( 4.65) 107.88( 2.91) 
Hb 12.41(1.79) 12.71( 1.97) 
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Analysis of hemodynamic parameters 
The hemodynamic parameters intraop and postoperatively were analysed. Table 4 
shows the mean fall in blood pressure. The fall in mean between the groups was not 
statistically significant. 
 Table 4: Maximum Fall in intraoperative blood pressure and 
postoperative blood pressure 
Group N lowest intraop 
mean 
SD Lowest post 
op mean 
SD Sig 
CVP group 29 57.9 6.65 73.5 6.6 .063 
PPV group 28 54.6 8.2 76.2 7.7 .179 
 
The distribution of lowest blood pressures were as shown in the figure 1 
Fig 1: Distribution of lowest intraoperative blood pressure in both groups 
 
Series 1: CVP group  Series 2: PPV group 
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Analysis of acid base status 
The change in the pH was analysed. The distribution of pH between the groups is as 
shown in figure 2. Most patients n=36 had a pH in the normal range .  
    Fig 2: Distribution of post op pH between CVP and PPV groups 
 
 
Figure 2: comparison of post operative pH in both groups 
   Group1:CVP  Group2: PPV 
20% of patients had mild acidosis and the difference between the groups was not 
statistically significant. 
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Analysis of tissue perfusion 
The serum lactate at the end of surgery was analysed in the groups. We found that 30 
patients had lactate value between 2.1- 4,  at the end of surgery. The distribution of the 
values between the groups were as shown in figure 3 
 
           Fig 3    Distribution of lactate values between the two groups 
 
Group 1-CVP Group 2-PPV 
The data was stratified based on the lactate values into 2 groups as less than 4 and 
more than 4 
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Considering that lactate values depend on the total fluid used and hypothermia  
and  estimated blood loss we compared these variables between the two groups as 
shown in table 5 
Table 5: Distribution of serum lactate values and the variables 
influencing it 
Lactate <4 Lactate>4 
 Cvp group PPV group P  CVP group PPV group  P  
Mean  SD Mean SD mean SD Mean SD 
Estimatedloss 659.5 378.4 1129.4 854.9 0.27 956.2 1128 1154 962 0.26
Total fluids 2545.2  
 
893. 3041.1 1719.2 
 
0.63 3500   3186.24 
 
3459.09  1771.414 
 
0.39
Change in pH -.06  .069 
 
-.076  .0526 
 
0.5 -.078   .0570557  
 
-.07   .0536656 
 
0.8
 
 
We found no significant difference between the two groups with regard to these 
variables. 
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 Table 6: Estimation of blood loss in both groups and comparison of 
pre and post op Hb. 
Group Number  Mean blood 
loss 
SD Hbpre Hbpost
CVP 29 777.5 665 12.4  9.9 
PPV group 28 1101.7 913 12.7  9.7 
Significance 0.00 0.41 0.71 
 
We found a significant difference in the total estimated blood loss between both groups. 
However the preoperative and post operative haemoglobin was comparable in both 
groups.  
 
Amount of fluids used: 
The amount of fluid used in the intraoperative period was compared between the two 
groups. The fluids were categorised as crystalloids , colloids and blood .The distribution 
was as shown in table 7. 
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 Table 7:Intra operative fluid management                       
Group  Crystalloids   Colloids Blood  
Median P25 P75 median P25 P75 Median P25 P75
CVP 1500 1200 2000 500 500 500 0 0 350
PPV 2250 1500 3000 500 250 1000 175 0 550
P value .002 0.57 .142  
 
As shown in the table the median value for colloid use was similar in both groups. The p 
value was significantly different for the use of crystalloids between both groups. This 
was probably secondary to the increased blood loss in the PPV group. This is 
graphically represented in figure 4 
Fig 4: Distribution of total fluids between both groups  
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In patients from the groups with post operative lactate more than 4 we analysed the 
total amount of fluid used and the factors influencing fluid management namely the 
estimated blood loss, size of the tumour and the duration of surgery.  
Table 9 shows the factors influencing fluid management in both groups. 
Table 9: Factors influencing fluid management in CVP and PPV group 
in patients with post op lactate >4 
                     CVP group 
MEAN               SD 
PPV group 
MEAN              SD 
P value 
Estimated 
loss 
741.3793   685.704 
 
1139.286   
 
881.9546 0.10 
Duration  303.1034   
 
71.65659 314.2857   120.4983   
 
0.97 
Tumour size 5.072414   1.422246 
 
5.003571   
 
1.795979 0.83 
 
As seen from the table there was no significant difference between the variables .  
Chloride and abnormal pH 
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Chloride value was available in 31 cases. The arterial blood gas we used did not 
provide chloride value.random sampling of chloride was done in few patients to ensure 
that acidosis was not due to hyperchloremia.  
We found no correlation between the change in chloride levels and abnormal pH 
in these patients in both groups 
Post operative fluid boluses and fluid management 
The postoperative hemodynamics as mentioned earlier and the amount of fluid 
boluses required were documented. The number requiring fluid boluses were almost 
equally distributed between the groups as shown in figure 4 
Fig 4: Distribution of number of fluid boluses in the post operative 
period 
 
 
59 
 
 
Discussion  
Fluid management in neurosurgery is specially challenging to the anaesthesiologist as 
the indices commonly used to guide fluid replacement is inappropriate in these patients. 
Blood loss estimation is erroneous in view of the use of fluid for irrigation and the 
concealed loss under the drapes. Urine output cannot be used as an index due to the 
use of osmotic diuretic like mannitol. The use of central venous pressure may not be 
reliable in the different positions patients are operated upon. Direct arterial pressure 
monitoring is routinely done in neurosurgery and if cardiovascular monitors used in the 
OR have the facility to measure PPV, this monitoring is easily achieved in most patients.  
Our aim in this study was to see if PPV can be used as an index to predict fluid 
requirement in neurosurgery. We also compared fluid therapy using PPV against CVP 
guided fluid therapy as control which is commonly used during major operations. 
Studies have favoured the use of PPV in high risk bowel surgery and in coronary artery 
bypass grafting over CVP. (44)(54) 
We enrolled 60 patients but analysed the results in 57 patients. 3 patients were 
excluded due to the need for post operative elective mechanical ventilation. Both patient 
groups were comparable with regard to the demography and co- morbid illnesses. All  
patients belonged to ASA grade 1&II. Our study showed that PPV is a good index of 
fluid management in neurosurgical patients, based on the intraoperative hemodynamics 
and the acid base status and lactate levels. We compared this therapy with CVP guided 
fluid therapy and found that hemodynamic parameters, acid base status and lactate 
were comparable in both groups. Though there is a significant difference in the amount 
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of crystalloid used in the PPV group, we attribute it to the larger blood loss (mean 1129 
Vs 659 in the CVP group) .While using PPV we aimed to achieve a value of < 13%. 
However when using CVP, it is a trend that we follow and not absolute numbers. In 
dehydrated patients such as neurosurgical patients on osmotic diuretic fluid therapy, 
following a trend may not be safe as the baseline reading may not be optimum. 
Besides, in patients with cardiac dysfunction, fluid therapy with CVP may not be 
advisable. Since all our patients belonged to ASA Class I&II, we considered CVP to be 
representative of left sided pressures. We used ECG guided internal jugular cannulation 
for all patients and positioned the tip at the atrio-caval junction for standardisation.  We 
routinely use peripherally inserted central venous catheterisation via the brachial vein 
for neurosurgical procedures, so the correct position of the catheter cannot be 
ascertained without the use of radiology, echocardiography etc., which may not be 
feasible on a routine basis. Measuring PPV is much simpler if the facility is available in 
the OR. Our study proved that PPV is a reliable monitor for intraoperative use, this  
being a dynamic index measuring fluid responsiveness.  Our study included mostly 
patients in supine position and lateral positions, and we found PPV to be consistent in 
these positions. More study needs to be done to ascertain the reliability in other 
positions such as prone and sitting. Among the other dynamic indices of hemodynamic 
variables, PPV has been found to be better than systolic pressure variation.  
The fall in mean blood pressure in both groups were compared. We found that 38  
patients had a mean BP less than 60. The drop in blood pressure was mostly found in 
the considerable long period between induction and incision.  There was no significant 
difference between the groups.                                   
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The fluid requirement in both cases was evaluated taking into consideration the 
variables controlling fluid management. Fluids given depend on the duration of surgery , 
estimated blood loss and the size of the tumour. The duration of surgery and the size of 
tumour were comparable. Estimated blood loss was significantly more in the PPV group 
explaining the significantly larger crystalloid use in the PPV group. Though patients 
received larger volume no patients had symptoms and signs of fluid overload. 
Another aim of our study was also to evaluate adequacy of tissue perfusion as 
evaluated by serum lactate levels. We tried to control the factors influencing lactate 
levels and thus excluded patients with sepsis, high baseline lactate, patients on lactic 
acidosis producing drugs. Intraoperatively we tried to avoid hypothermia. The 
temperature was in the range of 35-36 degrees intraoperatively. The data was 
categorised into 2 groups based on lactate as <4 and >4.  We analysed the factors 
influencing serum lactate in both groups like change in pH, estimated blood loss and the 
amount of fluid required to restore perfusion. Though 24 of 57 patients had a lactate 
value above 4 we found no statistical difference between the two groups (p value 0.26, 
0.38,0.8) despite the larger blood loss and fluid requirement in the PPV group. The 
probable explanation for the increase in lactate could be hypothermia which is normally 
found in these patients with the large volume of fluid used for irrigation and the 
temperature in the OR. Many patients had an initial lower temperature though by the 
end of surgery the temperature had come up to 36 in most patients. Interestingly, there 
were quite a number of patients who had baseline lactate above normal range.  
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Post operative fluid management was left to the intensivist who had no idea of which 
group the patient belonged. The amount of fluid infused has a reflection on the 
intraoperative management as postoperative blood loss in neurosurgical patients is 
minimal unless they develop haematoma. No patient required rexploration. The protocol 
for fluid administration in the ICU is to give boluses of 500 ml of fluid if there is a trend in 
drop of blood pressure. 30 out of 57 patients did not require any boluses. The lowest 
blood pressure and the number of fluid boluses used were analysed between the 
groups. The number of patients who required boluses were more in the CVP group. 
There were no patients in the PPV group who required more than 2 boluses. The 
reason for the lack of statistically significant difference in the two groups could be the 
small number of patients.  
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Conclusion: 
1. Our study proves that pulse pressure variation (PPV) is a reliable and easily 
monitored index for fluid therapy in neurosurgical patients undergoing 
craniotomies in supine and lateral position. 
2. Fluid management using PPV is as efficacious as using CVP as a guide for fluid 
management in patients with normal cardiac function. Despite a significantly 
larger blood loss in the PPV group, intraoperative hemodynamic stability and 
postoperative acid base and lactate level were comparable in the two groups. 
3. No patient had signs of fluid overload in either group.  
4. The acid base status was acceptable in both groups. Though PH were within 
normal limits, both groups had patients with higher than normal lactate levels. 
The cause for lactate cannot not be explained on the blood loss, change in pH, 
volume of fluid infused, duration of surgery or size of tumour.  
5. There was no significant hemodynamic instability in any patient in the 
postoperative period.  
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Recommendation: 
1. We recommend the use of PPV as a guide to fluid management in all 
neurosurgical patients especially when significant blood loss is expected. 
2. We recommend more studies comparing PPV and CVP in patients requiring 
surgery in various positions such as prone, sitting, concorde and in high risk 
patients to establish the usefulness of PPV and perhaps the superiority of PPV in 
these situations.   
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Annexures: 
 
Patient information sheet and consent form: 
The study in which you will be participating is a research project to compare two 
methods of administering intravenous fluids during the surgery that you are about to 
undergo; i.e craniotomy.(in neurosurgery wher e the skull  bone is opened ). At the end 
of the study we hope to evaluate if one method of giving fluids is better than the other in 
terms of any increased requirement of fluids after the operation, stability of blood 
pressure after the surgery, accumulation of acid in the blood which occurs with 
inadequate fluids. If we can validate this method of giving fluids we will be able to avoid 
post operative problems in such patients. 
You will be enrolled in this trial when you undergo the operation.  You will not be subject 
to any new procedures apart from those done normally for this kind of surgery.  You will 
be given general anesthesia and all intervention will be done during the surgery based 
on the two methods of giving fluids.allthe measurements are done electronically and 
you will not be subject to any discomfort.  We do not anticipate any major side effects 
due to the two methods because both are used commonly in such operations . Your 
blood pressure readings and amount of fluid given to you will be recorded by us  during 
the operation. After the operation you will be observed in the intensive care unit as is 
the routine in such cases.  
In case of any queries related to the trial you can contact Dr.Shalini Cynthia, Dr, Amar, 
Dr. Grace Korula from the department of anaesthesia. Your participation is entirely 
voluntary and you are free to opt out of the study at any time you feel inconvenienced 
by it.  Opting out entails no penalties in any form. 
There will be approximately 60 patients involved  in the study. 
INFORMED CONSENT 
Study Title: 
Study Number: 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age:_______ 
Please initial box  
(Subject) 
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(i) I confirm that I have read and understood the information sheet dated _________ for 
the above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected. [ ] 
 (iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission 
to look at my health records both in respect of the current study and any further 
research that may be conducted in relation to it, even if I withdraw from the trial. I agree 
to this access. However, I understand that my identity will not be revealed in any 
information released to third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
Consent will be obtained by the principal investigator performing the study before   the 
patient is subjected to the surgery in the ward.The information sheet has been made 
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available in the vernacular spoken by the patient and the patient will also be explained 
the process in his vernacular language by persons competent in that language.  The 
consent will be obtained at the bed side in the ward for patients who are admitted  
The patient will not be required to incur any expense for the study. The information 
gathered from the study will be maintained in strict confidentiality and will be known only 
to the investigator. It will not be disclosed or used for any purpose other than this study. 
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Study protocol and data entry sheet: 
Data  entry  sheet :   
Roll No:                         Sex:                                               Age: 
ASA grade: 
Height :                                     Weight :                                BMI: 
Co morbidities: 
Medications: 
Preoperative investigations:  
Hb/PCV                                        Creat                                Platelets: 
Tumour histology: 
Tumour size from MRI scan: 
Type of surgery: 
Parameters: 
  Preinduction Post induction End of surgery
Heart rate   
Blood pressure   
Mean art 
pressure 
 
CVP   
PPV   
 
 
Lowest blood pressure recorded:  
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ABG recording   At start of surgery At end of surgery 
pH   
pCO2   
paO2   
Sao2   
Lactate     
Na   
K   
Calcium   
Hemoglobin   
ABE   
 
Fluids given: (in ml) 
Normal saline 
Ringer lactate 
Colloid (please specify) 
Whole blood 
Packed cells 
FFP’s 
Other  
 
 
Post operative period: 
Lowest blood pressure recorded 
Total fluids given post operatively  
Blood transfused 
Post op PCV 
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THESIS PROTOCOL: 
Comparison of CVP and PPV guided  fluid  therapy  in patients planned  for supine 
and lateral position craniotomy surgery.  
 
Patients planned for tumour excision in supine and lateral position: 
Preinduction : 
Large bore intravenous cannula under LA 
Arterial line to be established under LA 
Arterial blood gas to be done with patient breathing room air. 
Monitoring ECG, Arterial BP, EtCO2, Pulse oximeter 
Induction: 
 fentanyl upto 2 mcg/kg, thiopentone 5 mc/kg, vecuronium 0.1mg/kg. 
Isoflurane at 1‐5‐2% to maintain endtidal concentration at 0.9‐1 
Intraoperative period: 
Single  lumen central venous cathether  to be put  into  right  internal  jugular vein 
using ECG control and fixed at the point where the p wave decreases in amplitude 
after becoming biphasic. 
Mechanical ventilation with tidal volume of 8ml/kg and appropriate rate. 
Baseline PPV and CVP  to be noted down.  In PPV group  fluids  to be given every 
time PPV value was more than 13 
In CVP group fluids to be given to maintain baseline CVP. 
Temperature to be maintained between 36‐37degree Celsius 
Vecuronium  infusion  to  be  started  and  titrated  to  get  2  twitches  on 
neuromuscular monitoring. 
Normal saline and ringer lactate to be used alternatingly and blood loss replaced 
with colloid or blood depending on the Hb . 
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If BP is unstable inspite of adequate fluid therapy and normal PPV and CVP values 
vasoconstrictor like Phenylephrine or ephedrine to be used.  
PPV and CVP reading at the end of surgery to be noted before discontinuing 
mechanical ventilation  
Extubation: 
Reversal with neostigmine and glycopyrollate. Extubate when fully awake. 
Arterial blood gas to be repeated when patient maintains saturation on room air. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
group no hospitalno duration sex age asagrade weight height
1 1 523159 210 2 40 1 47 160
1 3 519438 300 2 33 1 55 155
1 5 494273 300 1 49 1 64 154
1 8 584309 230 2 35 1 45 150
1 9 533207 210 2 42 2 66 155
1 10 556539 300 2 36 1 44 160
1 13 615546 240 1 63 2 74 164
1 14 622646 330 2 48 3 64 154
1 16 663186 390 2 43 1 44 155
1 18 629080 240 2 55 2 61 160
1 21 675398 270 1 61 2 75 165
1 22 676127 330 1 51 1 60 168
1 26 683463 300 1 27 1 73 167
1 28 680442 330 2 33 1 63 160
1 32 756271 420 2 45 1 50 150
1 33 716692 310 2 40 1 57 153
1 35 696628 420 2 55 2 55 155
1 40 637142 300 2 25 1 52 152
1 43 704525 360 1 66 1 44 160
1 44 731814 240 1 47 1 75 179
1 47 734251 285 1 38 1 61 164
1 48 974698 300 2 39 1 42 155
1 51 714043 180 2 48 1 57 155
1 52 709050 225 1 29 1 53 154
1 54 700772 420 2 41 1 55 156
1 56 752106 300 1 40 1 52 163
1 58 735635 300 2 51 2 53 155
1 59 757588 270 1 39 2 67 166
1 60 732860 480 1 41 1 61 160
2 2 524538 120 1 25 1 45 155
2 4 524927 420 2 45 1 50 160
2 6 560052 240 2 27 1 80 158
2 7 454249 195 2 58 2 69 155
2 11 584536 90 1 60 1 50 150
2 12 593582 300 2 49 1 51 152
2 15 386942 280 2 69 2 57 152
2 17 654767 480 2 30 1 58 154
2 19 641997 405 2 29 1 80 164
2 20 681901 420 1 61 2 61 160
2 23 710736 240 2 37 2 49 150
2 24 659086d 330 1 36 1 57 157
2 25 681821d 420 1 63 2 60 165
2 30 675518 270 2 44 1 46 152
2 31 682973 630 2 30 1 54 160
2 34 725236 240 1 28 1 63 165
2 36 707871 210 2 45 2 45 144
2 38 722927 300 2 37 1 62 149
2 39 725314 315 1 36 1 60 165
2 41 695142 270 2 34 1 46 156
2 42 678246 300 2 45 2 74 155
2 45 730190 255 2 27 1 50 156
2 46 739878 570 1 20 1 54 164
2 49 728685 300 2 35 1 51 148
2 50 744977 225 2 37 1 62 160
2 53 735694 405 1 22 1 75 164
2 55 723914 300 1 63 1 60 160
2 57 679875 270 1 27 1 79 164
bmi comorbid1 comorbid2 antiepilept steroid medicationmedicationpcv creat
18.3 0 0 1 1 0 0 34 0.7
22.9 0 0 1 1 0 0 30 0.8
27 0 0 1 1 0 0 35 0.7
20 2 0 0 0 5 0 35 0.7
27.5 4 0 1 0 0 0 36.9 0.7
17.1 0 0 1 0 0 0 32.3 0.7
27.6 2 3 0 0 7 3 40.9 0.9
27 2 0 0 0 5 0 37.5 0.6
18.3 0 0 1 1 0 0 30.4 0.8
23.8 2 0 1 1 5 0 36 0.9
27.5 1 2 1 1 3 5 42.5 1.1
21.3 0 0 0 0 0 0 43.5 1
23.7 0 0 1 1 0 0 48 1
24.6 0 0 1 1 0 0 29.9 1
22.2 0 0 1 1 0 0 36.8 0.8
24.3 0 0 0 1 0 0 35.7 0.8
22.9 1 2 1 1 3 5 37.3 0.9
22.5 0 0 1 1 0 0 36 0.8
17.1 0 0 1 1 0 0 39 1.2
23.4 0 0 1 1 0 0 39.9 0.9
22.7 0 0 1 1 0 0 40.3 1
20 0 0 1 1 0 0 36.9 0.8
23 0 0 1 1 0 0 34.7 1
23.3 0 0 1 1 0 0 42 1
23 0 0 1 0 0 0 37.8 0.8
19.6 0 0 1 1 0 0 49.5 1.1
22.1 2 0 0 1 5 0 30.1 0.7
24.3 2 0 1 1 5 0 38.6 1.2
23.8 0 0 1 1 0 0 41.8 0.9
18.7 0 0 1 1 0 0 45 0.8
19.5 0 0 0 1 0 0 38 0.7
32.1 0 0 1 0 0 0 40 0.8
28.7 1 2 1 1 4 0 38 1.1
22.2 0 0 1 1 0 0 30.2 1.1
22 0 0 0 1 0 0 36.1 0.7
24.6 2 0 1 0 5 0 32.7 1.1
24.4 0 0 1 0 0 0 37.5 0.9
29.7 0 0 1 1 0 0 38.3 0.9
23.7 0 0 1 1 0 0 40.8 0.9
21.8 1 0 1 1 3 0 33.2 0.7
23.1 0 0 1 1 0 0 40.8 1
22 1 2 1 1 3 5 45.1 1.3
19.9 0 0 1 1 0 0 37.8 0.8
21 0 0 1 1 0 0 33.1 0.9
23.1 0 0 1 1 0 0 42.5 1
21.7 1 0 1 1 3 0 36 0.7
27.9 0 0 1 1 0 0 35.8 0.8
22 0 0 1 1 0 0 44.5 1
18.9 0 0 1 1 0 0 29.8 0.7
30.8 4 0 1 1 8 0 37.7 0.7
22.2 0 0 1 1 0 0 31 0.9
19.3 0 0 1 1 0 0 38.4 0.9
23.3 0 0 1 1 0 1 38.7 0.8
24.2 0 0 1 1 0 1 26.7 0.9
27.9 0 0 1 1 0 0 42.2 0.9
23.4 0 0 1 0 0 0 37.2 1.1
29.4 0 0 1 1 0 0 42.8 0.9
histology sizeoftumo typeofsurg syspre diaspre meanpre deltasys syspost diaspost meanpost
1 7 2 129 76 93 ‐7 122 78 93
1 5 2 109 74 86 2 141 90 107
1 4.5 5 116 78 91 ‐1 110 70 83
1 5 7 146 65 92 2 130 80 96
2 5 1 143 70 94 8 127 71 90
1 5.7 6 127 76 93 ‐7 110 82 91
1 5 7 111 77 88 ‐10 160 80 106
2 8.2 7 153 83 106 ‐11 135 65 88
1 4.5 5 112 64 80 ‐6 137 81 99
1 3.2 1 150 73 98 ‐11 116 70 85
1 3 6 164 76 105 ‐24 130 80 96
1 5.9 4 140 89 105 ‐23 125 80 95
1 8 5 120 70 86 22 133 82 99
1 5 2 132 80 97 ‐10 163 88 113
1 5.3 2 120 84 96 ‐21 123 72 89
1 4.5 4 137 78 97 8 120 70 87
1 5.7 1 150 86 107 10 115 66 82
2 3 3 118 64 82 ‐3 147 67 94
1 4.5 2 91 59 70 4 105 55 79
4.4 7 118 89 98 ‐4 110 63 79
1 4.2 1 104 47 66 ‐28 132 62 85
6 7.3 3 110 54 73 20 160 95 116
1 2.5 2 100 59 73 ‐10 120 70 87
3 4.5 3 117 79 91 32 146 70 95
1 4 5 125 71 89 7 155 88 110
1 5 1 110 72 85 18 138 66 90
1 4.2 4 130 70 90 ‐2 130 78 95
1 6 2 137 86 103 ‐18 122 78 93
1 7 1 130 70 90 44 144 76 99
4 6 1 139 73 95 20 140 76 97
1 4 4 128 74 92 13 150 80 103
1 2.3 2 117 63 81 ‐1 130 70 90
1 2 6 170 82 111 ‐10 140 81 100
2 6 2 154 75 101 ‐30 190 104 130
1 5 4 148 87 107 7 120 76 90
1 2 1 154 84 107 11 126 82 97
1 5.1 7 105 65 78 8 126 62 83
1 5 1 101 65 77 ‐15 125 75 91
1 3 1 114 68 83 10 135 71 92
1 4 1 130 76 94 8 99 60 73
1 8.5 7 114 63 80 6 124 70 89
1 8 1 148 81 103 ‐10 100 58 72
1 5 1 140 71 94 0 120 70 87
1 4.4 1 100 60 73 15 119 60 80
5 6 1 131 95 107 8 118 52 74
1 4.6 2 220 110 146 28 120 84 99
1 3 7 113 63 80 14 120 70 86
1 4.2 6 115 69 85 9 109 56 74
1 6 6 140 64 89 21 138 90 91
1 2 1 125 69 88 5 125 60 82
1 7 5 110 62 78 ‐10 115 57 76
7.5 1 120 76 90 10 130 90 103
1 7 7 92 60 71 2 112 76 88
1 6 1 106 67 80 ‐14 126 78 94
1 6 6 120 70 87 20 150 70 96
1 5.2 1 120 80 93 3 140 77 98
1 5.3 6 140 80 100 ‐25 105 66 79
hrpre hrpost deltahr cv pre cvp post deltacvp ppv pre ppvpost deltappv
79 110 31 4 3 ‐1 12 15 3
58 109 51 5 4 ‐1 6 7 1
65 76 10 8 9 1 13 12 ‐1
92 78 ‐14 8 4 ‐4 8 8 0
108 87 ‐21 12 11 ‐1 9 10 1
103 106 3 7 10 3 9 10 1
87 92 5 7 8 1 10 8 ‐2
62 80 18 9 9 0 10 6 ‐4
73 105 32 7 6 ‐1 12 19 7
84 113 92 9 8 ‐1 10 11 1
114 130 16 3 0 ‐3 10 8 ‐2
113 103 ‐10 6 12 6 17 8 ‐9
87 104 14 10 10 0 8 4 ‐4
70 90 20 1 1 0 6 4 ‐2
99 120 21 9 5 ‐4 10 4 ‐6
98 104 6 10 15 5 10 13 3
79 108 29 8 8 0 13 8 ‐5
78 89 11 9 10 1 7 7 0
87 96 9 7 8 1 10 5 ‐5
76 123 47 11 13 2 6 10 4
76 89 13 10 13 3 12 7 ‐5
82 90 8 5 9 4 5 11 6
94 86 ‐8 10 9 ‐1 6 7 1
84 116 32 6 9 3 13 6 ‐7
80 88 8 7 4 ‐3 13 13 0
74 88 14 8 6 ‐2 18 6 ‐12
92 90 ‐2 10 9 ‐1 5 5 0
81 88 7 8 9 1 5 5 0
80 112 32 7 9 2 13 12 ‐1
82 82 0 9 11 2 10 7 ‐3
96 120 24 6 6 0 18 11 ‐7
73 104 31 6 4 ‐2 8 12 4
114 120 6 6 10 4 7 9 2
58 90 32 6 6 0 8 10 2
85 95 10 5 6 1 9 8 ‐1
77 92 15 6 8 2 11 15 4
91 104 13 6 4 ‐2 10 10 0
94 90 ‐4 8 11 3 8 16 8
79 86 7 9 10 1 4 10 6
78 88 10 9 14 5 9 10 1
95 98 3 5 6 1 10 6 ‐4
64 72 8 3 3 0 9 13 4
73 130 57 7 2 ‐5 10 10 0
78 89 11 4 6 2 11 7 ‐4
87 110 23 1 4 3 11 7 ‐4
96 100 4 6 5 ‐1 13 5 ‐8
90 100 10 8 8 0 9 12 3
97 104 7 7 6 ‐1 9 9 0
98 108 10 4 5 1 8 8 0
72 87 15 6 7 1 10 11 1
103 82 ‐21 4 5 1 6 6 0
80 85 5 6 3 ‐3 6 7 1
82 108 26 7 9 2 12 11 ‐1
82 72 ‐10 10 10 0 12 8 ‐4
55 80 25 9 8 ‐1 14 7 ‐7
89 98 9 8 8 0 11 14 3
60 84 24 12 14 2 4 25 21
lowestsys lowestdias meanpre meanlowesfallinmeandtempext lowesttem pre_ph pH_ post
92 54 93 66 27 36.1 35.8 7.42 7.28
82 46 95 58 37 34.5 33.9 7.43 7.33
80 48 86 59 27 37 35.6 7.48 7.38
76 40 92 52 40 35.5 35.5 7.4 7.35
97 59 91 72 19 37.7 36.8 7.43 7.39
83 46 81 58 23 36.3 36.5 7.42 7.35
92 45 111 60 51 36.2 35.9 7.4 7.32
78 46 92 56 36 36.5 36 7.46 7.42
79 52 94 61 33 35.6 35.4 7.47 7.37
83 42 93 55 38 35 34.7 7.47 7.29
78 42 101 54 47 36.4 36 7.49 7.33
63 41 107 48 59 35.5 34.5 7.47 7.34
66 44 88 51 37 35.5 35.2 7.46 7.32
72 35 106 47 59 35.9 35 7.42 7.44
86 41 107 56 51 35.8 35.4 7.43 7.27
85 45 80 58 22 36.5 36.2 7.5 7.41
77 41 78 53 22 36 35.3 7.48 7.43
84 45 98 58 40 36.4 35.9 7.46 7.33
80 44 77 56 21 36.6 35.4 7.39 7.42
68 40 83 49 34 36.3 35.9 7.44 7.39
81 44 105 56 49 36.5 36.1 7.45 7.38
90 59 105 69 36 36.6 35.6 7.46 7.45
105 50 94 68 26 37.6 37.1 7.43 7.4
85 39 80 54 26 35.6 35 7.38 7.29
88 55 103 66 37 36.3 35.8 7.45 7.44
79 52 86 61 25 36.6 36.2 7.5 7.4
90 60 97 70 27 36.9 35.7 7.44 7.44
69 44 94 52 42 37 35.8 7.46 7.38
87 52 73 63 10 36.9 35.7 7.44 7.39
70 40 96 50 46 36.2 36.6 7.49 7.43
82 46 97 58 39 35.9 34.9 7.44 7.4
83 51 107 61 46 36.7 36.2 7.43 7.37
75 31 107 46 61 36.4 35.3 7.41 7.32
84 60 146 68 78 36.2 35.9 7.46 7.32
84 44 80 53 27 36.8 36.5 7.46 7.425
82 54 85 63 22 36.5 35.9 7.47 7.31
66 36 82 46 36 36.9 36.9 7.39 7.3
76 41 89 53 36 35.5 35 7.45 7.36
96 50 88 61 27 36 35.7 7.39 7.35
80 53 70 64 14 36.4 36.2 7.64 7.37
84 51 98 64 34 36.1 35.5 7.46 7.36
43 21 78 28 50 36 35.7 7.46 7.35
80 47 90 58 32 37.3 36.3 7.36 7.41
75 42 66 53 13 36.1 35.7 7.43 7.35
84 44 73 53 20 35.5 35 7.34 7.37
73 40 71 53 18 36 35.1 7.5 7.45
88 48 80 53 27 36 35.9 7.45 7.4
77 44 73 55 18 36 35.6 7.41 7.31
74 42 91 53 38 35.8 35.3 7.46 7.45
86 48 87 60 27 36.8 35.6 7.4 7.31
81 43 89 56 33 37.6 36.3 7.46 7.47
80 40 93 53 40 36.2 36.2 7.43 7.34
80 49 85 59 26 37.3 35.5 7.4 7.4
77 50 100 59 41 36.5 36.1 7.45 7.33
74 41 90 52 38 35.4 36.1 7.45 7.41
78 52 103 61 42 37.1 36.1 7.4 7.37
59 27 90 38 52 35.4 36.1 7.39 7.37
 pCO2_pre pCO2_ pst fiO2 paO2pre paO2post saO2pre saO2post HCo3pre HCO3post
41 43 60 516 366 100 100 25.6 18.7
43 43 21 102 136 98 99 27.4 21.1
36 35 60 372 160 100 99 25.7 19.7
30 27 21 84 81 97 95 18 14
43 46 21 86 90 97 97 27.4 26.7
34 38 21 91 90 97 96 21.25 19.7
35 51 21 84 76 96 94 26 24
42 39 21 81 109 96 98 29 25.3
40 44 21 87 132 97 99 29 25
33 35 21 102 123 99 98 24 16.8
30 46 21 109 144 99 99 22.9 24.3
34 40 21 88 95 97 97 24.7 21.6
36 45 21 111 211 99 100 25.5 23.2
41 38 40 156 204 99 100 26.6 25.8
29 41 21 76 83 95 94 19.2 18.8
33 35 21 107 98 99 98 25.2 22.2
35 36 21 97 114 98 99 26.1 23.9
41 53 21 62 74 93 94 29.2 27.9
37 34 21 91 80 97 96 22.4 22.3
38.5 36.1 60 224 236 97.4 97.5 26.5 22.3
39 42 21 70 73 95 94 27.1 24.8
37 33 21 96 124 98 99 26.3 22.9
37.6 37.7 21 71 113 94.7 97.7 25.3 23.9
39 32 21 80 100 95 97 23 15
39 37 21 114 93 99 98 27.1 25.1
36 38 21 87 84.8 97 96 28 24
34 31 21 81 115 96 99 23.1 21.1
25.7 31.2 21 114 91 98 97 21.3 20.1
30.9 29.6 40 134 112 98.3 98.4 22.8 19.6
35.3 36.1 21 96.9 85.4 98 97 27.8 24.5
39 39 100 324 313 97 100 26.5 24.2
38.8 40.5 21 94 112 97.8 98 26.1 23.2
44 46 60 239 209 97.3 99 27.1 22.8
35.8 46.8 21 90 82 97 95 26.1 23.8
32.2 30.3 21 80 91 96 99.6 23 20.2
33.6 43.8 40 134 130 98.4 98.9 24.5 21.6
36.8 38.3 21 106 102 97 99 22.9 18.8
26.7 31.8 21 88 139 97 98.8 20.8 27.7
34.5 39.7 21 60.7 88 90 98 21 22
34.6 37.1 21 86 98 96.6 97.2 25.8 21.8
30.4 40.1 60 311 234 99 99 21.3 22.7
33 43 21 83 119 96 97 25 23
47 42 60 172 250 99 100 25.6 25.5
39.2 37.5 21 86 102 96.7 97.2 25.9 20.9
53.5 40.1 21 73.5 126 94 98 26.5 23.2
36.8 39.4 21 96 122 98 99.8 29.4 27.5
32.5 33.6 60 228 263 99 99 23.8 21.8
31.8 38 60 282 266 99.7 99.5 21.4 19.1
34.8 36.9 21 83 97 96.9 95.9 25.8 24.5
45 47.4 21 93 98 97 99 27.5 24.5
20.9 29 21 99 93 98 98 19.6 23.1
36.6 42 21 71 96 95 98 24.8 22.4
43.5 36.7 21 75.5 101 95 97.9 26.4 23.3
34.4 39.7 21 87.9 89 96.6 95.8 25 20.5
33.2 35 21 81 114 96.1 98 24.8 22.9
41.3 36.8 21 87.4 91.3 96.6 97 25.3 21.5
41 36.7 21 85 95.4 97 98 24.5 21.8
lactatepre lactatepostdeltalactateABEpre ABEpost Na _pre Na_post K_pre K_ post
1.3 3.8 2.5 1.9 ‐6.5 133 141 3.3 3.4
1.6 2.8 1.2 4.2 ‐3.2 140 143 3.2 3.7
1.6 2.9 1.3 3.2 ‐3.4 132 136 4.1 3.5
3.8 5.7 1.9 ‐3.8 ‐10.7 143 147 3.7 3.4
2.4 3.2 0.8 3.7 2.3 137 141 3.8 3.8
2 3.1 1.1 ‐2.4 ‐4.6 138 139 3.4 3.9
1 1.8 0.8 1.2 0.2 135 136 3.9 4.5
1.5 2.4 0.9 6.1 0.8 138 142 3.6 3.3
1.8 3.4 1.6 5.4 0.1 139 138 3.8 3.5
3.2 5.8 1.4 0.7 ‐9.8 133 142 3.6 4.6
8.8 8.5 ‐0.3 ‐0.4 ‐1.6 130 129 3.9 3.8
0.5 1.2 0.7 1 ‐4.2 135 139 3.8 3.9
2.2 4 1.8 1.8 ‐2.9 134 132 4.5 4.8
1.7 3.5 1.8 1.9 1.6 131 134 3.7 4
3.7 4.8 1.1 ‐4.1 ‐7.6 135 135 4 5
2.2 6.4 4.2 2.5 ‐2.4 136 137 3.5 3.8
2.6 4.8 2.2 2.6 ‐0.4 136 137 4 3.8
2.7 2.5 ‐0.2 5.4 2 131 130 4 3.9
3.8 4.7 0.9 ‐2.6 ‐2.4 132 136 3.7 3.8
1.6 6.5 4.9 2.3 ‐2.5 132 139 3.8 3.4
1.4 2.9 1.5 3.1 ‐0.3 139 140 3.5 3.6
1.3 1.8 0.5 2.5 ‐1.1 139 145 2.8 3.1
1.3 3.5 2.2 1 ‐0.7 135 135 3.6 3.7
4 7.2 3.2 ‐2 ‐11 134 138 4.2 4.2
0.8 1.8 1 3.1 0.9 131 136 4.8 3.7
2.9 3.1 0.2 4.9 ‐0.4 133 140 4.1 4.1
2.4 4.3 1.9 ‐1.1 ‐3.1 135 138 4 4
4 6 2 ‐4.9 ‐5.3 137 139 3.6 4.2
2.2 5 2.8 ‐2 ‐5.9 131 137 3.8 3.8
2.1 3.3 1.2 3.8 ‐0.1 130 136 3.9 3.8
0.9 2.7 1.8 2.3 ‐0.6 131 131 3.4 3.7
2.1 5 2.9 1.9 ‐1.5 136 135 4.1 4.3
3.2 3.1 0.1 3 ‐1.9 134 140 3.6 3.3
2.1 1.9 ‐0.2 1.9 ‐1.7 137 139 3.6 3.6
2 2.6 0.6 0 ‐3.8 136 141 3.6 3.7
1.2 3.4 2.2 2.1 ‐3.8 133 135 3.7 4.3
1.9 4.8 2.9 ‐1.8 ‐7 135 137 3.6 3.6
3.3 3.5 0.2 ‐4.3 ‐6.5 137 141 3.3 3.6
3.2 3.5 0.3 ‐2.9 ‐2.8 136 140 3.6 3.4
1.1 2.1 1 1.6 ‐3.1 132 136 3.6 3.6
1 2.9 1.8 ‐1.3 12 134 135 3.2 4.4
1.5 2.5 1 0.8 ‐1.5 135 140 3.6 3.5
1.8 1.2 ‐0.6 1.3 0.9 138 146 3.5 3.5
2.4 4.4 2 1.8 ‐4.4 137 140 3.8 3.9
1.1 3.6 2.5 2.5 ‐1.4 130 135 9.2 4
3.1 4.8 1.7 5.5 3.4 135 140 3.7 3.5
0.7 2.5 1.8 ‐0.8 ‐3.1 137 137 3.9 4.4
2.8 4.5 1.7 ‐3.7 ‐6.5 137 136 4 4.7
0.9 1.8 0.9 1.6 0.1 135 136 2.7 3.2
1.6 3.6 2 3.5 ‐2 136 136 3.9 3.9
2.6 3.4 0.8 ‐5.9 ‐1.6 138 136 2.6 4.1
0.8 2.8 2 0.5 ‐2.4 136 137 4.4 3.7
2 3.3 1.3 2.4 ‐1.4 136 137 3.8 4.6
2 2.4 0.4 0.8 2.9 136 137 3.4 3.8
1.8 4 2.2 0.2 ‐1.8 140 139 3.4 3.6
2.3 6.3 4 1.1 ‐3.5 131 132 3.7 4.1
1.8 6.9 5.1 0.1 ‐3.1 138 144 3.7 3.6
Ca_pre Ca_ post cl_pre cl_post Hb_pre Hb_post Fluid _NS  RL  Colloid
1.11 0.4 12 8.9 1500 0 500
1.07 1.04 14.7 10.9 1200 0 500
1.05 1.01 10.2 6.5 1100 1100 500
1.11 0.79 12.6 6 2500 500 1000
1.16 1.08 12.2 10.5 1000 0 500
1.11 1.08 12.5 10.5 1300 0 500
1.1 1.1 12.4 12.4 1000 0 0
1.12 1.07 11.5 9.9 1500 500 0
1.18 1.09 12.7 10.5 1000 500 0
1.05 0.9 11 8 1500 0 2000
1.08 1.04 10.2 8.4 1000 0 0
1.14 1.03 14.4 11.6 2000 0 1500
1.15 0.98 12.1 9.9 1600 0 500
1.09 1.07 9.9 9 500 700 500
1.09 1.1 12.3 9.3 1500 0 500
1.07 0.9 11 10.3 1500 0 400
1.14 1.07 14.3 10 1500 100 500
1.07 1.01 13 10 1000 0 500
1.16 1.01 14 10.5 2000 0 500
1.15 1.07 101 112 13.6 6.8 2500 1000 2000
1.14 1.05 15.3 11.5 1500 0 500
1.16 1.12 15.4 13 2250 0 0
1.13 1.06 10.5 9.3 650 500 0
1.15 1.05 15.8 12.3 3000 0 500
1.01 1 13.7 8.4 1500 0 500
1.12 1.2 103 106 16.5 13.1 2000 0 1000
1.14 1.09 11.9 10.9 1000 0 500
1.1 1.05 111 113 13 10.7 1000 500 500
1.16 1.12 107 113 10.5 9.3 2500 500 1000
1.02 1.01 102 110 11.6 8.5 2000 1000 1000
1.07 1.09 11.8 9 1500 0 500
1.14 1.08 107 112 13.5 11.7 1500 500 1000
1.07 0.93 103 115 12.8 9 2000 500 0
1.1 0.99 107 112 12.8 9.6 1000 0 500
1.1 0.95 107 113 11 8 1500 500 500
1.08 0.97 107 114 16.8 10.3 2000 1000 1000
1.15 1.1 107 111 12 10.8 1500 1000 500
1.13 0.94 111 118 9.9 8.9 2500 500 500
1.13 1.17 112 115 11.9 11.7 2000 1000 0
1.12 1.03 108 114 14.2 9.3 1500 0 700
0.98 1.05 111 111 11.7 11.6 1500 500 0
1.13 1.1 109 115 10.1 8.9 2500 1500 1000
1.18 1.1 109 120 13.7 10.1 2500 1500 1500
1.12 1.02 110 115 12.6 11.8 2000 200 0
1.15 1.14 106 111 12.3 9.2 1000 500 500
1.04 0.96 104 112 11.7 7.8 2500 1000 500
1.05 0.98 110 113 8.8 9 1000 500 0
1.09 1.1 113 113 10.3 9.6 1500 500 0
1.08 1.08 108 110 12.5 10.2 1500 1000 500
1.19 0.8 105 107 14.7 8.9 1000 500 1500
0.8 0.9 118 112 10.9 8.1 2100 700 1000
1.03 1.07 111 111 11.2 9.2 1000 1000 500
1.1 1.02 108 117 16.7 11.9 2000 1000 1000
1.07 0.95 108 113 15.4 12.4 1500 500 0
1.01 1.07 113 113 9.6 9 1000 500 500
1.13 1.05 101 107 12.9 10.1 1000 250 500
1.22 0.9 108 114 13.2 9.7 3000 2500 2500
type _of_ f Wholebloo PackedcellsFFP  totalfluids estimatedlolowestsys_ lowestdias_meanposto
1 350 0 0 2350 1100 90 60 70
1 0 0 0 1700 400 100 60 73
1 0 350 0 3050 800 80 60 66
1 0 0 0 4000 1200 84 50 61
1 850 0 0 2350 1600 100 60 73
1 0 0 0 1800 600 97 70 77
0 0 0 0 1000 400 110 70 83
0 0 0 0 2000 400 100 70 80
0 0 0 0 1500 200 100 70 80
1 700 0 0 4200 1000 90 60 70
0 0 0 0 1000 150 100 60 73
1 350 700 0 4550 1600 100 70 80
1 0 0 0 2100 100 110 70 83
1 0 0 0 1700 500 95 47 63
1 0 0 0 2000 500 110 70 83
1 350 0 0 2250 800 100 60 73
1 0 0 0 2100 550 100 60 73
1 0 0 0 1500 500 90 60 70
1 0 0 0 2500 800 90 60 70
1 1700 0 0 7200 3500 100 60 73
1 0 0 0 2000 400 100 60 73
0 0 0 0 2250 500 110 65 80
0 0 0 0 1150 300 100 70 83
1 0 0 0 3500 400 90 60 70
1 0 0 0 2000 800 86 42 57
1 0 0 0 3000 750 100 60 73
1 0 0 0 1500 300 108 60 76
1 350 0 0 2350 900 100 60 73
1 1000 0 0 5000 1500 100 60 73
1 700 0 0 4700 1500 100 70 80
1 0 0 0 2000 500 110 60 77
1 0 350 0 3350 1000 90 60 70
0 500 0 0 3000 1000 80 60 66
0 0 0 0 1500 250 130 80 97
1 0 0 0 2500 900 120 60 80
1 350 0 0 4350 2000 74 56 62
1 0 0 0 3000 300 100 60 73
1 1400 0 0 4900 2500 90 50 63
0 0 0 0 3000 400 90 50 63
1 0 0 0 2200 600 110 70 83
0 0 0 0 2000 300 100 70 80
1 1400 0 0 6400 2800 100 60 73
1 1000 0 0 6500 1800 100 70 80
0 0 0 0 2200 350 100 70 80
1 0 0 0 2000 500 110 70 83
1 1050 0 0 5050 2200 100 70 80
0 500 0 0 2000 450 100 60 73
0 0 0 0 2000 300 100 60 73
1 0 0 0 3000 600 100 70 80
1 0 350 0 3350 2000 90 60 70
1 600 0 0 4400 600 100 70 80
1 0 0 0 2500 350 90 70 77
1 0 0 0 4000 700 100 60 73
0 500 0 0 2500 1650 98 70 79
1 350 0 0 2350 700 110 60 77
1 0 0 0 1750 800 100 60 73
1 1000 2100 0 11100 3800 110 16.5 90
fallinmeanpfluidbolus totalfluids bloodtrans packedcell wholebloodffp prc CRYO
23 1 1750 0 0 0 0 0 0
22 0 1400 0 0 0 0 0 0
20 3 3900 1 350 0 0 0 0
31 1 2400 2 700 850 0 0 0
18 1 2625 0 0 0 0 0 0
4 2 3600 0 0 0 0 0 0
28 0 1700 0 0 0 0 0 0
12 0 1850 0 0 0 0 0 0
14 0 1750 0 0 0 0 0 0
73 2 1900 1 0 700 0 0 0
28 0 2100 0 0 0 0 0 0
27 0 1700 0 0 0 0 0 0
5 0 1350 0 0 0 0 0 0
43 3 3600 0 0 0 0 0 0
24 0 2300 0 0 0 0 0 0
7 1 3200 0 0 0 0 0 0
5 4 3900 0 0 0 0 0 0
28 1 3050 1 0 350 0 0 0
7 3 3100 0 0 0 0 0 0
10 2 2900 1 0 500 0 2 0
32 0 2150 0 0 0 0 0 0
25 2 2300 0 0 0 0 0 0
11 2 2250 0 0 0 0 0 0
10 1 2575 0 0 0 0 0 0
46 3 3100 1 0 350 0 0 0
13 0 1500 0 0 0 0 0 0
21 0 3500 0 0 0 0 0 0
21 0 2400 0 0 0 0 0 0
0 1 2800 0 0 0 0 0 0
16 0 1250 0 0 0 0 0 0
20 0 2150 0 0 0 0 0 0
37 0 1350 0 0 0 0 0 0
41 2 2900 1 0 500 0 0 0
49 1 2200 0 0 0 0 0 0
0 1 1750 0 0 0 0 0 0
23 2 3600 1 350 0 0 0 0
9 0 2100 0 0 0 0 0 0
23 0 2120 0 0 0 0 0 4
25 0 1350 0 0 0 0 0 0
‐13 0 2100 0 0 0 0 0 0
18 1 1850 0 0 0 0 0 0
5 1 2200 1 350 0 0 0 0
10 0 2500 0 0 0 0 0 0
‐14 1 2350 0 0 0 0 0 0
‐10 0 1350 0 11.5 0 0 0 0
‐9 0 4650 0 0 0 0 4 5
7 1 1900 0 0 0 0 0 0
0 0 2300 0 0 0 0 0 0
11 0 1800 0 0 0 0 0 0
17 0 2120 0 0 0 0 0 0
9 0 1350 0 0 0 0 0 0
16 0 2050 0 0 0 0 0 0
12 1 1750 0 0 0 0 0 0
21 1 2000 0 0 0 0 0 0
13 0 2160 0 0 0 0 0 0
30 0 1750 0 0 0 0 0 0
0 0 1870 0 0 0 0 8 4
postop_ pc postopdurahospitalno
27.2 12 523159
34 20 524538
25.2 18 519438
22.2 10 524927
30.2 18 494273
29.8 18 560052
34.5 13 454249
29.4 14.5 584309
34.2 15 533207
37.6 12 556539
31.6 20 584536
39.5 15 593582
39.2 14.5 615546
27.7 16 622646
30.2 18 386942
27.3 12 663186
29.6 14.5 654767
26.8 15 629080
30.1 15.5 641997
30.8 10 681901
37.6 15 675398
34.4 16.5 676127
25 710736
32 17 659086d
27.6 15 681821d
40.8 11.5 683463
26.5 16 680442
28.7 18 675518
28.8 12 682973
26.7 9.5 756271
30.3 17 716692
36 11.5 725236
35.3 10 696628
34.2 10.5 707871
28.8 11.5 722927
35.7 12 725314
32.4 17 637142
27.7 12 695142
33.5 11.59 678246
35.7 9 704525
32.6 17 731814
21.5 10 730190
30.1 10.5 739878
36.7 17.5 734251
29 10 974698
29.4 11.5 728685
30.9 18.5 744977
27.4 19 714043
36 11 709050
30.6 16.5 735694
27.7 11 700772
25.7 17 723914
38.9 11 752106
37 11.5 679875
25.5 18 735635
32.7 15 757588
25.5 14.5 732860
